New start-up Antelope Dx raises 5.1 million EUR

(21-08-2019) The Antelope technology is the result of ten years of research at the Photonics Research Group of Ghent University.

Since mid-last year, the technology has been further incubated in MyCartis and the newco is now established as a spin-off from UGent and MyCartis.

An investment consortium, with RMM (Rudi Marien) and Saffelberg (Jos Sluys) as lead investors, has invested in the new spin-off Antelope Dx. Together with some high net worth individuals, they have invested 5,1 million EUR in the new diagnostic company that develops innovative technology and applications for point-of-care testing. 

Read full article

Learn more about Antelope Dx